Piperaquine

DB13941ApprovedInvestigationalSmall molecule

Piperaquine is an antimalarial agent first synthesized in the 1960's and used throughout China . Its use declined in the 1980's as piperaquine resistant strains of Plasmodium falciparum appeared and... It has come back into use in combination with the artemisinin derivative DB11638 as part of the combination product Eurartesim.

Chemical structure of Piperaquine
Mechanism
Curator reviewed
Primary indication
For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg.Curator reviewed · 1 structured indication
Formula / weight
C29H32Cl2N6 · 535.52 g/mol (avg)
First approval
European Union, 2021
Brand names
  • Eurartesim

Resolves to

Structure
InChIKeyUCRHFBCYFMIWHC-UHFFFAOYSA-NSMILESClC1=CC2=C(C=C1)C(=CC=N2)N1CCN(CCCN2CCN(CC2)C2=CC=NC3=C2C=CC(Cl)=C3)CC1
Transporters

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
615Drug interactionsStructured to mechanism, not free text
Sign in
119Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
15Marketed productsAcross 4 countries and 5 labellers
Sign in
3ATC codesIncluding every combination product, plus 24 drug categories
Sign in
24+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Piperaquine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account